PMID: 7032379Jan 1, 1982Paper

Ineffectiveness of aspirin and dipyridamole in the treatment of thrombotic thrombocytopenic purpura

Annals of Internal Medicine
M H RosoveDennis Goldfinger

Abstract

Platelet-inhibiting drugs have been used widely in the treatment of thrombotic thrombocytopenia purpura. Nineteen consecutive patients received various treatments including platelet inhibitors, glucocorticoid drugs, whole blood or plasma exchange transfusions, and splenectomy. During treatment with aspirin and dipyridamole in 14 patients, five died, and only one had neither new neurologic signs nor worsening thrombocytopenia. Prostacyclin in one patient was not beneficial. Serious bleeding complications, including massive upper gastrointestinal hemorrhage, epistaxes, or subarachnoid hemorrhage confirmed at autopsy, occurred in five of the 19 patients and only during treatment with aspirin and dipyridamole. We conclude that there is no evidence for the effectiveness of aspirin and dipyridamole in the treatment of thrombotic thrombocytopenic purpura and that these drugs may increase the risk of serious bleeding complications.

Citations

May 20, 1998·Journal of Clinical Apheresis·C MazzeiD Goldfinger
Jan 1, 1990·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·J M Bergstein
Nov 2, 2004·Annals of Hematology·Pavan S ReddyMervin A Sahud
Mar 22, 2000·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Y TakahashiT Tamaya
Aug 28, 2003·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Gerlando QuintiniGuglielmo Mariani
Dec 2, 1982·The New England Journal of Medicine·A J Marcus
Aug 23, 2002·The New England Journal of Medicine·Joel L Moake
Jan 1, 2010·Mediterranean Journal of Hematology and Infectious Diseases·Evi Stavrou, Hillard M Lazarus
Dec 24, 2013·Seminars in Arthritis and Rheumatism·Michael H Rosove
Nov 6, 2009·Wiener klinische Wochenschrift·Lea SalamonJadranka Morovic-Vergles
Jun 11, 2011·Expert Opinion on Investigational Drugs·Patrizia Noris, Carlo L Balduini
Aug 1, 1987·Kidney International·G Remuzzi
Jan 24, 2012·La Presse médicale·Paul Coppo, Agnès Veyradier
Apr 27, 2010·Medicina clínica·Javier de la RubiaJulio Del Río-Garma
Nov 13, 2001·Mayo Clinic Proceedings·M A Elliott, W L Nichols
Mar 31, 2007·The Journal of Emergency Medicine·Jenny K McCormickDavid F M Brown
Jan 1, 1993·Nihon rinsho. Japanese journal of clinical medicine·T Koyama, E Kakishita
Apr 1, 1988·Journal of the American Geriatrics Society·C L Knupp
Feb 18, 2003·British Journal of Haematology·Sarah L AllfordUNKNOWN Haemostasis and Thrombosis Task Force, British Committee for Standards in Haematology
Jan 31, 2002·Annual Review of Medicine·Joel L Moake
Mar 12, 2003·Hematology/oncology Clinics of North America·Chadi Nabhan, Hau C Kwaan
Jan 1, 1987·Annals of the New York Academy of Sciences·J G Kelton, W G Murphy
Dec 1, 1986·American Journal of Hematology·E T LiuM A Shuman
Aug 1, 1989·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Y EzraA Eldor
Apr 26, 2006·Vox Sanguinis·S FontanaB Mansouri Taleghani
Apr 1, 2006·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Daniel PatschanStefan Herget-Rosenthal
Apr 1, 1987·American Journal of Hematology·J B BlitzerH Lamberson
Feb 1, 1983·American Journal of Hematology·M T Schreeder, J T Prchal
Mar 1, 1983·Hospital Practice·N S NahmanJ N Parsons

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.